Document is current
Any future updates will be listed below
-
Authors
Liu, Chen-Chung https://orcid.org/0000-0002-9290-110X
Takeuchi, Hiroyoshi
-
Funding
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (MOST 106-2314-B-002-106)
Ministry of Science and Technology, Taiwan (MOST 107-2314-B-002-222-MY3)
- License Information
-
More Information
Article History
First Online: 18 November 2019
Compliance with Ethical Standards
:
: Chen-Chung Liu received research Grants MOST 106-2314-B-002-106 and MOST 107-2314-B-002-222-MY3 from the Ministry of Science and Technology, Taiwan. Chen-Chung Liu has also received speaker’s honoraria from Janssen-Cilag Pharma. Hiroyoshi Takeuchi has received research grants from the Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, and SENSHIN Medical Research Foundation. Hiroyoshi Takeuchi has also received speaker’s honoraria from Meiji-Seika Pharma, Mochida, Otsuka, Sumitomo Dainippon Pharma, and Yoshitomi Yakuhin, and manuscript fees from Sumitomo Dainippon Pharma. The funding sources did not participate in the preparation, review, approval, or decision to submit this manuscript for publication.
: Chen-Chung Liu and Hiroyoshi Takeuchi have no conflicts of interest that are directly relevant to the content of this article.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the hospital’s research ethics committee (NTUHREC No. 201703002RIND) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: All participants provided written informed consent to participate.
